Sargent Bickham Lagudis’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$98K Buy
1,865
+1,265
+211% +$64.2K 0.01% 337
2022
Q3
$28K Sell
600
-193
-24% -$10K ﹤0.01% 516
2022
Q2
$40K Buy
793
+1
+0.1% +$55 ﹤0.01% 466
2022
Q1
$49K Hold
792
﹤0.01% 457
2021
Q4
$52K Hold
792
﹤0.01% 441
2021
Q3
$50K Hold
792
﹤0.01% 443
2021
Q2
$48K Hold
792
﹤0.01% 458
2021
Q1
$44K Hold
792
﹤0.01% 456
2020
Q4
$43K Buy
792
+192
+32% +$10K ﹤0.01% 451
2020
Q3
$30K Hold
600
﹤0.01% 453
2020
Q2
$26K Hold
600
﹤0.01% 448
2020
Q1
$23K Buy
+600
New +$25.3K ﹤0.01% 443

Other funds holding IHI

Sargent Bickham Lagudis's IHI Position: Q4 2022 in Review

Sargent Bickham Lagudis increased its iShares US Medical Devices ETF (IHI) stake by 211% in Q4 2022, buying an estimated $64.2K and bringing the position to 1,865 shares worth $98K. The position accounts for 0.01% of the portfolio, ranked #337.

Sargent Bickham Lagudis first reported a position in IHI in Q1 2020 and has held it in 12 quarters since. 577 funds tracked by Wall St. Rank hold IHI as of Q4 2022.

  • Sargent Bickham Lagudis held 1,865 shares of iShares US Medical Devices ETF worth $98K as of Q4 2022.
  • Sargent Bickham Lagudis bought 1,265 iShares US Medical Devices ETF shares in Q4 2022, an estimated $64.2K.
  • iShares US Medical Devices ETF made up 0.01% of Sargent Bickham Lagudis's portfolio in Q4 2022, its #337 holding.
  • Sargent Bickham Lagudis first reported a position in iShares US Medical Devices ETF in Q1 2020 and has held it in 12 quarters since.
  • 577 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.